OR WAIT null SECS
© 2022 MJH Life Sciences and Rheumatology Network. All rights reserved.
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Data from the COSMOS study showed that 44.4% of patients who received guselkumab versus 19.8% of patients who received placebo achieved a ≥20% improvement at week 24.
Study participants who received combined video and booklet education were more effective in changing self-care behaviors. The education tools additionally provided greater advantages for Spanish-speaking and less-educated patients.